David J Woodhouse - Net Worth and Insider Trading
David J Woodhouse Net Worth
The estimated net worth of David J Woodhouse is at least $123,200 dollars as of 2024-04-29. David J Woodhouse is the CEO of NGM Biopharmaceuticals Inc and owns about 80,000 shares of NGM Biopharmaceuticals Inc (NGM) stock worth over $123,200. Details can be seen in David J Woodhouse's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David J Woodhouse has not made any transactions after 2021-11-18 and currently still holds the listed stock(s).
Transaction Summary of David J Woodhouse
David J Woodhouse Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David J Woodhouse owns 3 companies in total, including NGM Biopharmaceuticals Inc (NGM) , Surrozen Inc (SRZN) , and Consonance-HFW Acquisition Corp (CHFW.U) .
Click here to see the complete history of David J Woodhouse’s form 4 insider trades.
Insider Ownership Summary of David J Woodhouse
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NGM | NGM Biopharmaceuticals Inc | 2021-11-18 | director & CEO and acting CFO |
| SRZN | Surrozen Inc | 2021-08-11 | director |
| CHFW.U | Consonance-HFW Acquisition Corp | 2021-08-11 | director |
David J Woodhouse Latest Holdings Summary
David J Woodhouse currently owns a total of 1 stock. David J Woodhouse owns 80,000 shares of NGM Biopharmaceuticals Inc (NGM) as of November 18, 2021, with a value of $123,200.
Latest Holdings of David J Woodhouse
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NGM | NGM Biopharmaceuticals Inc | 2021-11-18 | 80,000 | 1.54 | 123,200 |
Holding Weightings of David J Woodhouse
David J Woodhouse Form 4 Trading Tracker
According to the SEC Form 4 filings, David J Woodhouse has made a total of 1 transactions in NGM Biopharmaceuticals Inc (NGM) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in NGM Biopharmaceuticals Inc is the sale of 15,000 shares on November 18, 2021, which brought David J Woodhouse around $300,300.
Insider Trading History of David J Woodhouse
- 1
David J Woodhouse Trading Performance
David J Woodhouse Ownership Network
Ownership Network List of David J Woodhouse
Ownership Network Relation of David J Woodhouse
David J Woodhouse Owned Company Details
What does NGM Biopharmaceuticals Inc do?
Who are the key executives at NGM Biopharmaceuticals Inc?
David J Woodhouse is the director & CEO and acting CFO of NGM Biopharmaceuticals Inc. Other key executives at NGM Biopharmaceuticals Inc include director & 10 percent owner David V Goeddel , 10 percent owner Column Group L P , and Chief Financial Officer Jean-frederic Viret .
NGM Biopharmaceuticals Inc (NGM) Insider Trades Summary
Over the past 18 months, David J Woodhouse made no insider transaction in NGM Biopharmaceuticals Inc (NGM). Other recent insider transactions involving NGM Biopharmaceuticals Inc (NGM) include a net purchase of 2,247,495 shares made by Column Group L P , a net purchase of 753,345 shares made by David V Goeddel , and a net sale of 85,082 shares made by Jin-long Chen .
In summary, during the past 3 months, insiders sold 0 shares of NGM Biopharmaceuticals Inc (NGM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 85,082 shares of NGM Biopharmaceuticals Inc (NGM) were sold and 3,000,840 shares were bought by its insiders, resulting in a net purchase of 2,915,758 shares.
NGM Biopharmaceuticals Inc (NGM)'s detailed insider trading history can be found in Insider Trading Tracker table.
NGM Biopharmaceuticals Inc Insider Transactions
David J Woodhouse Mailing Address
Above is the net worth, insider trading, and ownership report for David J Woodhouse. You might contact David J Woodhouse via mailing address: 630 Gateway Blvd., South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
